These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3730459)

  • 1. Low-dose (0.5-mg) dexamethasone suppression test in depressive patients.
    Sarai M; Matsunaga H
    Biol Psychiatry; 1986 Jul; 21(8-9):744-50. PubMed ID: 3730459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of serum dexamethasone concentrations in the dexamethasone suppression test.
    Carr V; Morris H; Gilliland J
    Biol Psychiatry; 1986 Jul; 21(8-9):735-43. PubMed ID: 3730458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test: interaction of diagnosis, sex, and age in psychiatric inpatients.
    Nelson WH; Khan A; Orr WW; Tamragouri RN
    Biol Psychiatry; 1984 Sep; 19(9):1293-304. PubMed ID: 6498252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI; Ryan CE; Kohn R; Miller IW; Norman WH; Brown WA
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M; Taniguchi N; Kagomoto T; Kameda H; Uema T; Hishikawa Y
    Folia Psychiatr Neurol Jpn; 1982; 36(2):109-14. PubMed ID: 7129257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between post-dexamethasone cortisol level and blood pressure in depressed inpatients.
    Pfohl B; Rederer M; Coryell W; Stangl D
    J Nerv Ment Dis; 1991 Jan; 179(1):44-7. PubMed ID: 1985149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects.
    Amsterdam JD; Winokur A; Caroff SN; Conn J
    Am J Psychiatry; 1982 Mar; 139(3):287-91. PubMed ID: 7058940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E; Eskola J; Ruuskanen O; Laine T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in organic affective syndrome.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1984 Nov; 141(11):1465-7. PubMed ID: 6496794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL; Nemeroff CB
    J Psychiatr Res; 1987; 21(2):185-94. PubMed ID: 3585807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone kinetics in depressed patients before and after clinical response.
    Maguire KP; Tuckwell VM; Schweitzer I; Tiller JW; Davies BM
    Psychoneuroendocrinology; 1990; 15(2):113-23. PubMed ID: 2359809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic heterogeneity and the DST in consecutive psychiatric admissions.
    Keitner GI; Haier RJ; Qualls CB; Brown WA; McKendall MJ
    Psychiatry Res; 1985 Mar; 14(3):215-23. PubMed ID: 3858894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metyrapone test in affective disorders and schizophrenia.
    Fava GA; Carson SW; Perini GI; Morphy MA; Molnar G; Jusko WJ
    J Affect Disord; 1984 Jun; 6(3-4):241-7. PubMed ID: 6235255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.